Cargando…
Fool’s gold, lost treasures, and the randomized clinical trial
BACKGROUND: Randomized controlled trials with a survival endpoint are the gold standard for clinical research, but have failed to achieve cures for most advanced malignancies. The high costs of randomized clinical trials slow progress (thereby causing avoidable loss of life) and increase health care...
Autores principales: | Stewart, David J, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639810/ https://www.ncbi.nlm.nih.gov/pubmed/23587187 http://dx.doi.org/10.1186/1471-2407-13-193 |
Ejemplares similares
-
Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome
por: Dorantes, Oscar Armando
Publicado: (2021) -
The ethical justification for inclusion of neonates in pragmatic randomized clinical trials for emergency newborn care
por: Kaye, Dan Kabonge
Publicado: (2019) -
Medical education today: all that glitters is not gold
por: Buja, L. Maximilian
Publicado: (2019) -
Response to 'Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome'
por: McCallum, Richard
Publicado: (2021) -
Wearables for cardiac monitoring in athletes: precious metal or fool’s gold?
por: Fanous, Yehia, et al.
Publicado: (2021)